Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply

Detalles Bibliográficos
Autores principales: Mårtensson, Johan, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251585/
https://www.ncbi.nlm.nih.gov/pubmed/37291591
http://dx.doi.org/10.1186/s13054-023-04513-7
_version_ 1785055977574236160
author Mårtensson, Johan
Bellomo, Rinaldo
author_facet Mårtensson, Johan
Bellomo, Rinaldo
author_sort Mårtensson, Johan
collection PubMed
description
format Online
Article
Text
id pubmed-10251585
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102515852023-06-10 Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply Mårtensson, Johan Bellomo, Rinaldo Crit Care Correspondence BioMed Central 2023-06-08 /pmc/articles/PMC10251585/ /pubmed/37291591 http://dx.doi.org/10.1186/s13054-023-04513-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Mårtensson, Johan
Bellomo, Rinaldo
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title_full Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title_fullStr Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title_full_unstemmed Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title_short Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
title_sort sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? reply
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251585/
https://www.ncbi.nlm.nih.gov/pubmed/37291591
http://dx.doi.org/10.1186/s13054-023-04513-7
work_keys_str_mv AT martenssonjohan sodiumglucosecotransporter2inhibitorsintheintensivecareunitsettingdowereallyneedsodiumincreaseespeciallyinsepsisreply
AT bellomorinaldo sodiumglucosecotransporter2inhibitorsintheintensivecareunitsettingdowereallyneedsodiumincreaseespeciallyinsepsisreply

Ejemplares similares